For therapy, the function of SULT1C2 in promoting the growth, survival, migration, and invasiveness of HCC cells suggests that SULT1C2 may be inhibited for HCC treatment (Figures 2, 3, 4). Here, SULT1C2 is linked to hepatocellular carcinoma.